apigenin

apigenin chemical structure

Overview

Apigenin is a naturally occurring plant flavone, a subclass of flavonoids widely distributed in edible and medicinal plants. In biomedical research, it is commonly studied for its antioxidant, anti-inflammatory, and cytoprotective properties, as well as for its ability to participate in multi-component phytochemical systems and nanomedicine formulations. Across the recent studies provided here, apigenin appears as a bioactive constituent of herbal extracts and formulations, and also as a building block in carrier-free nanoparticle assemblies.

Biologically, apigenin is being investigated in relation to inflammatory signaling, oxidative stress, cardiovascular protection, and tissue injury responses. The recent literature contexts specifically connect it with pathways and targets such as NLRP3, Caspase-1, Gasdermin D (GSDMD), FOXO1/PDK4 signaling, and broader polyphenol-based therapeutic platforms that also involve tannic acid, Cu2+ ions, cannabidiol, kaempferol, quercetin, salidroside, naringenin, and related phytochemicals.

Recent Publications Summary

Apigenin has been examined across this recent literature primarily as a plant-derived flavone with anti-inflammatory and anticancer activity, and secondarily as a bioactive constituent used to characterize or standardize botanical extracts. In a dietary-glycoside study, apiin (apigenin-7-O-apiosylglucoside) was shown to resist host digestion and undergo microbial deglycosylation in the distal intestine to release apigenin as the bioactive aglycone; apiin administration was associated with reduced severity of DSS-induced colitis, lower TNF-α, IL-1β and IL-6, and restored intestinal barrier integrity, with multi-omics analyses linking these effects to reshaped gut microbiota, increased butyrate production, GPR41/GPR43 and PPARγ signaling, and attenuated NF-κB-driven inflammation 42448689Jul. This positions apigenin as the downstream effector of a microbiota-dependent biotransformation rather than as a directly absorbed dietary compound.

Anti-inflammatory and anticancer effects have been probed through combined network pharmacology, docking and in vitro or in vivo validation. In Dolichos lablab flower extract, apigenin (5.72% of the purified n-butanol fraction) and quercetin (4.06%) were the predominant constituents among 44 identified compounds, with apigenin predicted to act on core targets including TNF, IL6 and PTGS2 and showing strong docking affinity for TNF (ΔG = −10.9 kcal/mol); the extract suppressed pro-inflammatory cytokines in LPS-stimulated RAW 264.7 macrophages 42383440Jul. An in silico screen of Scutellaria barbata identified apigenin, 4′-hydroxywogonin and hispidulin as favorable drug-like flavonoids acting on the hub targets AKT1, IL6 and TNF within PI3K-Akt, MAPK and TNF signaling, with apigenin binding at −7.7 kcal/mol and hispidulin at −8.1 kcal/mol, nominating apigenin as an AKT1 inhibitor candidate in breast cancer 42348584Jun. In vivo, apigenin and chrysin were tested individually and in combination at 50 mg/kg orally for 8 weeks in a diethylnitrosamine/2-acetylaminofluorene rat model of hepatocellular carcinoma, with biochemical and histopathological endpoints assessed against DEN-induced activation of tumor-promoting signaling 42346026Jun.

Apigenin has also been incorporated into delivery systems and evaluated alongside other flavonoids in neuroprotection research. A biomimetic, macrophage-membrane-coated nanoparticle combined polysaccharide for immunomodulation, apigenin for cardiovascular protection and cannabidiol for neuroprotection into a single multi-target formulation, characterized physicochemically and tested for efficacy in a middle cerebral artery occlusion model of ischemic stroke 42003696Apr. In a phytochemical study of five Encephalartos species, apigenin was isolated from the ethyl acetate fraction of E. ferox together with naringenin and the biflavonoids amentoflavone, bilobetin and ginkgetin; the biflavonoids, rather than apigenin itself, carried the reported acetylcholinesterase inhibition (IC50 0.762–2.146 µg/mL versus rivastigmine at 3.357 µg/mL), and a validated HPLC-DAD method was developed for their simultaneous quantification 42443245Jul.

A further group of studies uses apigenin chiefly as an analytical marker of extract composition. Metabolomic profiling of Achillea arabica ethanolic extract by UHPLC-QTOF-MS² listed apigenin among the key constituents alongside chlorogenic acid, isorhamnetin, kaempferol-3-O-glucoside, naringenin and anthocyanin glycosides, underpinning the extract's antioxidant (DPPH IC50 135.99 µg/mL; ABTS IC50 422.02 µg/mL), antidiabetic and anti-inflammatory activities 42126671May, while response-surface optimization of ultrasound-assisted extraction from dandelion (Taraxacum officinale) maximized recovery of total phenolics (40.77 mg GAE/g) and flavonoids (22.68 mg RE/g) with HPLC profiling of individual bioactives 42068787May. Apigenin appears in a similar constituent-level role in work on multi-component traditional formulations: Yangxinshi Tablet improved cardiac function and mitochondrial energy metabolism in post-myocardial-infarction heart failure through inhibition of FOXO1/PDK4 signaling, with its components profiled by molecular docking and validated in cell-based assays, and the "Tianyu" formulation reduced NLRP3/caspase-1/GSDMD-mediated pyroptosis and IL-1β, IL-18 and TNF-α release in rheumatoid arthritis fibroblast-like synoviocytes and a collagen-induced arthritis rat model 42033182Apr. Collectively, these reports converge on inflammatory signaling — TNF, IL-6, NF-κB and PI3K-Akt — as the recurring axis through which apigenin is proposed to act, though most mechanistic support to date is computational or extract-level rather than derived from apigenin administered alone.

What Changes, What Holds

1. Apigenin now appears to act downstream of gut microbial deglycosylation rather than only as a directly absorbed flavone
NEW DIRECTION Apiin’s conversion to apigenin in the distal intestine adds a microbiota-dependent route to apigenin exposure and helps explain why the aglycone can mediate anti-colitic effects in a way that depends on host microbes, barrier repair, and short-chain fatty acid signaling 42448689Jul. This does not displace the established anti-inflammatory profile of apigenin, but it does narrow how its dietary bioavailability should be understood.

2. Recent screening work strengthens apigenin’s anti-inflammatory and anticancer candidacy but does not yet move it beyond a lead compound
REINFORCES The new extract-level, docking, and validation studies keep apigenin aligned with the baseline view of a flavone acting on inflammatory signaling and cancer-related targets, especially TNF, IL6, PTGS2 and AKT1 42383440Jul42348584Jun. What changes is mainly confidence in target plausibility and botanical relevance, not the underlying claim that apigenin is a bioactive anti-inflammatory phytochemical.

3. Apigenin is being pushed into combination delivery and comparative phytochemistry, not a new biological role
REINFORCES The nanoparticle formulation extends the existing nanomedicine context by packaging apigenin with other agents for multi-target use, while the Encephalartos study mainly treats it as one constituent among several flavonoids 42003696Apr42443245Jul. Neither result overturns the baseline; both reinforce apigenin’s utility as a component in complex formulations and analytical profiling rather than as a newly defined mechanism-specific drug.

4. Apigenin is increasingly used as a compositional marker in extracts whose activity is still attributed to mixed phytochemistry
METHOD Metabolomic and HPLC-oriented studies place apigenin among the compounds used to characterize botanical preparations with antioxidant, antidiabetic, anti-inflammatory, or cardiometabolic effects 42126671May42068787May42033182Apr. That shifts the emphasis toward standardization and mixture analysis, while leaving the baseline mechanistic story intact and still largely inferential rather than apigenin-alone driven.

Overview update candidates: microbiota-dependent release of apigenin from apiin; apigenin as a compositional marker in extract standardization and multi-component formulations.